Bone Biologics BBLGW
NASDAQ BBLGW
$8.24 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Bone Biologics Corp (BBLGW) Interest Coverage Ratio (2013 - 2025)

Bone Biologics (BBLGW) posted quarterly Interest Coverage Ratio of 8.3 for Q4 2025, up 53.6% year-over-year from 5.4 in Q4 2024, and down 181.13% quarter-over-quarter from 2.95 in Q3 2025.

Bone Biologics Corp (BBLGW) Interest Coverage Ratio (2013 - 2025) Analysis & Trends

Bone Biologics (BBLGW) has reported Interest Coverage Ratio for 13 consecutive years, with 8.3 the latest figure, recorded in Q4 2025.

  • In Q4 2025, Interest Coverage Ratio rose 53.6% year-over-year to 8.3; the TTM figure through Dec 2025 stood at 9.78 (up 79.84% YoY), while the FY2025 annual figure was 0.13, up 33.0% from the prior year.
  • Interest Coverage Ratio retreated to 8.3 in Q4 2025 per BBLGW's latest filing, from 2.95 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 0.59 in Q4 2021 and bottomed at 3003.38 in Q1 2023.
  • Historically, Interest Coverage Ratio has averaged 249.91 across 5 years, with a median of 2.95 in 2025.
  • Annual changes were most pronounced in 2021 — Interest Coverage Ratio soared 170.87% — and 2024, when it plunged 31373.26%.
  • Bone Biologics' Interest Coverage Ratio stood at 0.59 in 2021, then sank by 110.69% to 0.06 in 2022, then increased by 10.13% to 0.06 in 2023, then slumped by 31373.26% to 17.89 in 2024, then surged by 53.6% to 8.3 in 2025.
  • Business Quant data shows BBLGW's Interest Coverage Ratio at 8.3 in Q4 2025, 2.95 in Q3 2025, and 17.89 in Q4 2024.

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2025 -8.30
Sep 30, 2025 -2.95
Dec 31, 2024 -17.89
Sep 30, 2024 -25.80
Dec 31, 2023 -0.06
Sep 30, 2023 -115.54
Mar 31, 2023 -3,003.38
Dec 31, 2022 -0.06
Mar 31, 2022 -73.00
Dec 31, 2021 0.59
Sep 30, 2021 -0.82
Jun 30, 2021 -0.89
Mar 31, 2021 -0.72
Dec 31, 2020 -0.83
Sep 30, 2020 -0.59
Jun 30, 2020 -0.54
Mar 31, 2020 -1.33
Dec 31, 2019 -1.08
Sep 30, 2019 -1.16
Jun 30, 2019 -2.78